Genenta Science SPA (Genenta Science SPA) EPS (Basic) : $-0.70 (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Genenta Science SPA EPS (Basic)?

Genenta Science SPA's basic earnings per share (Basic EPS) for the six months ended in Dec. 2023 was $-0.29. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.70.

Genenta Science SPA's EPS (Diluted) for the six months ended in Dec. 2023 was $-0.29. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.70.

Genenta Science SPA's EPS without NRI for the six months ended in Dec. 2023 was $-0.29. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was -0.68.

During the past 3 years, the average EPS without NRI Growth Rate was -18.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, Genenta Science SPA's highest 3-Year average EPS without NRI Growth Rate was -18.30% per year. The lowest was -24.20% per year. And the median was -21.25% per year.

Genenta Science SPA EPS (Basic) Historical Data

The historical data trend for Genenta Science SPA's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genenta Science SPA EPS (Basic) Chart

Genenta Science SPA Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

-0.35

-0.46

-0.42

-0.50

-0.70

Genenta Science SPA Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EPS (Basic)	Get a 7-Day Free Trial				-0.09	-0.13	-0.37	-0.40	-0.29

Genenta Science SPA EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Genenta Science SPA's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-12.699	-	0)	/	18.217
	=	-0.70

Genenta Science SPA's Basic EPS for the quarter that ended in Dec. 2023 is calculated as

Basic EPS (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-5.328	-	0)	/	18.217
	=	-0.29

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.70

Genenta Science SPA (NAS:GNTA) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Genenta Science SPA EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Genenta Science SPA's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Genenta Science SPA (Genenta Science SPA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genenta Science SPA (NAS:GNTA) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

K5F:Germany

Address

Via Olgettina No. 58, Milan, ITA, 20132

Website

https://www.genenta.com

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's lead product includes Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.